Variation in responses to pathogens is influenced by exposure history, environment and the host's genetic status. We recently demonstrated that human leukocyte antigen class II allelic differences are a major determinant of the severity of invasive group A streptococcal (GAS) sepsis in humans. While in-depth controlled molecular studies on populations of genetically wellcharacterized humans are not feasible, it is now possible to exploit genetically diverse panels of recombinant inbred BXD mice to define genetic and environmental risk factors. Our goal in this study was to standardize the model and identify genetic and nongenetic covariates influencing invasive infection outcomes. Despite having common ancestors, the various BXD strains (n strains ¼ 33, n individuals ¼ 445) showed marked differences in survival. Mice from all strains developed bacteremia but exhibited considerable differences in disease severity, bacterial dissemination and mortality rates. Bacteremia and survival showed the expected negative correlation. Among nongenetic factors, age -but not sex or weight -was a significant predictor of survival (P ¼ 0.0005). To minimize nongenetic variability, we limited further analyses to mice aged 40-120 days and calculated a corrected relative survival index that reflects the number of days an animal survived post-infection normalized to all significant covariates. Genetic background (strain) was the most significant factor determining susceptibility (Pp0.0001), thus underscoring the strong effect of host genetic variation in determining susceptibility to severe GAS sepsis. This model offers powerful unbiased forward genetics to map specific quantitative trait loci and networks of pathways modulating the severity of GAS sepsis.
Introduction
There is now overwhelming evidence that specific genetic factors influence a host's susceptibility or immunity to many infectious agents, and modulate severity and outcome of infectious diseases. [1] [2] [3] [4] [5] Infection with group A streptococcus (GAS or Streptococcus pyogenes) represents an ideal model for studying effects of host genetics on disease. This human pathogen causes a wide variety of conditions ranging from sore throat to invasive life-threatening diseases (reviewed in Cunningham 6 ), and the same strain of pathogen leads to different outcomes in different individuals. 7 Our laboratory provided direct evidence that the highly polymorphic human leukocyte antigen (HLA) genes confer high risk or protection in rheumatic heart disease; 8 as well as in streptococcal toxic shock (STSS) and necrotizing fasciitis (NF). 9, 10 In GAS sepsis, allelic variation in HLA class II molecules plays a major role in modulating infection severity, primarily because they serve as binding and signaling receptors for superantigens, 11, 12 which are the primary trigger of the severe inflammatory responses that can lead to organ failure and shock. 13, 14 To systematically identify additional gene variants that modulate susceptibility to severe GAS sepsis and to elucidate how they influence disease outcome, we sought a robust experimental model of the disease with attributes that incorporate roughly the same level of genetic variation as that of human populations. Small numbers of conventional inbred mouse strains have been used previously to study differential susceptibility to GAS infection; [15] [16] [17] however, these models are limited in their genetic variability and cannot be used to map modifier loci. HLA transgenic mice are appropriate models for GAS sepsis, 18 but these too are generated on the genetic background of conventional inbred laboratory strains.
The genetically diverse mouse reference population of recombinant inbred (RI) strains, which can be likened to an immortal population of human monozygotic twins, is an ideal model for our studies. RI strains are generated by the crossing of two inbred strains followed by X20 consecutive generations mating among siblings. 19, 20 These types of strains are frequently used for studying genetic variation and mapping quantitative trait loci (QTL) influencing disease. 21, 22 The BXD strains were used recently to study variation in the pathogenicity of bovine spongiform encephalopathy and to uncover genes modulating anthrax and pox lethality. [23] [24] [25] Among the different panels of RI strains, we selected the BXD set produced from an intercross of C57BL/6J and DBA/2J. The parental strains are known to differ in response to many pathogens. [26] [27] [28] [29] The other notable advantage of this particular panel of RI strains is that both parental strains have been sequenced. 30 This makes it possible to use reverse genetic methods to test modifier genes. 31 We have 80 BXD strains that are being extensively phenotyped and genotyped.
As a first step in exploiting the BXD strains to study the genetics of GAS susceptibility, we have studied the influence of differences in sex, age, body weight, inoculum titer and genetic factors on disease development. Our main objective has been to develop a protocol that can be applied uniformly across the entire BXD set of 80. Our second objective has been to measure heritability and evaluate prospects of mapping modifier loci. We show the genetic and nongenetic factors that determine whether a mouse is protected from or susceptible to severe GAS sepsis. We evaluate the contribution of each of these factors using multivariate analysis, and we discuss the proper measures that should be followed to design experiments using this novel and promising mouse model in other infectious diseases and for elucidating the complex events of hostpathogen interactions.
Results
The main purpose of this study was to adapt and standardize the BXD RI model to investigate the genetic and molecular mechanisms associated with susceptibility to severe invasive GAS sepsis, to determine the nongenetic environmental factors affecting the model and to test whether the genetic variations among these mice would affect the progression and severity of invasive GAS disease. We used 717 mice in the study: 218 mice in the preliminary phase, 445 for the initial statistical analysis, 307 of which were selected for the final analysis as detailed below and 54 for the timecourse experiments.
Survival scores show differential susceptibility to severe GAS sepsis To assess the phenotype 'susceptibility or resistance of mice to severe GAS sepsis', we calculated a survival score for each animal as a quantitative trait: among 445 mice tested in six experiments, a notable variability was observed in survival scores measured as days postinfection. Interestingly, the distribution of the survival scores was not normal but multimodal, showing three groups (Figure 1a) , the largest of which represented animals (n ¼ 208) that died early (in less than 2.5 days). Another group included an intermediate population (n ¼ 125) that survived between 2.5 and 4.5 days, and the third group (n ¼ 112) survived for more than 5 days and up to the entire 7-day observation period. This pattern of survival was highly reproducible and predictable from one experiment to another with slight variability in the boundaries separating the three clusters in each experiment.
Bacterial loads in blood and organs show various degrees of bacteremia and tissue dissemination The bacterial load in blood (calculated as 'bacteremia index', BI ¼ log CFU (colony-forming unit)/ml blood sampled 24 h post-infection) was measured for 396 of 445 mice used in six experiments. In some cases, mice died before their blood was sampled, and in other cases the bacteria were too numerous to be counted by the plate dilution technique. In contrast to the survival scores, bacterial load followed a normal distribution (Figure 1b) . With the exception of few mice (n ¼ 6) whose blood was sterile (possibly due to injection failure), all mice had bacteremia with counts ranging from 125 (BI ¼ 2.097) to 1.72 Â 10 9 CFU/ml (BI ¼ 9.236), the mean BI7s.e. was 5.270.07 reflecting a highly symmetrical distribution.
Correlation analysis showed an inverse relation between survival scores and BI. The Pearson product moment-correlation factor of À0.430 (Figure 1c) indicates that the BI accounts for 20-30% of variance in mortality.
In addition to counting bacteria in blood, in some experiments we determined the bacterial dissemination in different systemic organs (mainly spleen, but also liver and lung) to estimate invasiveness of the disease. Among 335 mice with confirmed bacteremia, only 14 had sterile spleens while the remaining mice had bacterial counts ranging from 10 2 to 3 Â 10 10 CFU/spleen, with a median count of 1.3 Â 10 8 CFU/spleen. Bacterial loads in liver and lung were determined for 77 mice, and the median counts were 3.16 Â 10 9 CFU/liver and 2 Â 10 9 CFU/lung, with wide range of variation.
Statistical analysis evaluates the confounding factors affecting mice survival The variability in animal mortality and extent of bacteremia is not surprising and matches that reported in human infection [32] [33] [34] and in mice strains. 17 However, in this particular set of experiments, it was necessary to determine whether this variability reflects genetic differences between different BXD strains or whether it is mere biological variability caused by confounding factors like sex, body weight, animal age or experiment-to-experiment variability (due in part to differences in inoculum size or other experimental error). The large number of animals used and the availability of replenishable inbred BXD lines made such analysis possible and efficient.
First, we examined the effect of inoculum size. In preliminary experiments, we conducted a dose-response study in which we exposed animals to bacterial inocula ranging from 10 5 to 10 8 CFU/ml to find an optimal dose that would kill animals rapidly but would also discriminate between susceptible and resistant strains (data not shown). We chose an inoculum size of 271 Â 10 7 CFU/mouse because it showed clear differences between the parental strains (C57BL/6J and DBA/ 2J). However, because it is difficult to reproduce the inoculum titer in every experiment, and because precise counts could only be determined after injection, it was important to examine whether the interexperimental differences in inoculum size had an effect on survival. Slight variation in inoculum size had an insignificant effect on survival (r 2 ¼ 0.1%, P ¼ 0.533) (Figure 2a ). We tested whether sex had an effect on survival. Male mice (n ¼ 235) had a mean survival of 3.4970.12 days and a median of 3 days, slightly higher than female mice (n ¼ 206) that had a mean of 3.2570.12 days and a median of 2.3 days. This difference did not achieve statistical significance (P ¼ 0.153) (Figure 2b ).
Subsequently, we tested the effect of animal body weight and age on survival, and each of the two factors, independently, showed positive association with survival scores (Figure 2c and d) . Whereas weight had a correlation of 0.29, age had a stronger correlation factor of 0.44. It is noteworthy that weight was directly proportional with animal age between the ages of 40 and 120 days. Based on these findings, we decided to use animals in the age range of 40-120 days and to correct for age effects using a general linear model (GLM).
Analysis of covariates underscores the role of genetic background in determining animal susceptibility to GAS Having determined the effect of several major cofactors on survival scores, we set out to determine the complex interaction between these covariates and the genetic factor (that is, the mouse strain). At this stage of the analysis, we filtered our data set to exclude mice that were outside the 40-to 120-days age range (see above) and we selected BXD strains that had been used in at least two experiments. Table 1 lists mice selected for final analysis. We took advantage of the multimodal distribution of survival scores detailed above (see Figure 1a) to define a survival index (SI): animals were given a score ranging from 0.25 to 3, with increments of 0.25 (0.25 for most susceptible and 3.0 for most resistant). The use of SI was superior to survival scores as it normalized the data across experiments and minimized the unavoidable experiment-to-experiment variance in survival scores caused by slight differences in inoculum size and other systematic sources of error.
Finally, we performed GLM analysis of covariates using ordinary least-squares analysis of variance (OLS ANOVA) to determine the relative effect of covariates, including mouse strain, on survival (Table 2 ). This analysis revealed that strain was the most significant predictor (Pp0.0001), followed by age (P ¼ 0.0005) and weight (P ¼ 0.02). As shown before in Figure 2b , sex remained an insignificant factor in the final analysis (Table 2) . From the GLM, we estimate the main effect attributable to strain (a measure of heritability) to be 25-30% (42.21/152.44, see Table 2 ). This GLM analysis was not only helpful in assessing effects of several factors, but it also allowed us to generate a corrected relative survival index (cRSI), which was used to compare the strains and determine their relative susceptibilitycorrecting for differences in age and weight ( Figure 3 ).
BXD strains exhibited phenotype variability outside the range of the parental strains
The comparison of cRSI values between different strains ( Figure 3 ) reveals the stark effect that the genetic background plays in predicting how long a mouse will survive after being exposed to a high dose of GAS. Some strains have very low mean cRSI (for example, BXD66, BXD97 and BXD61) and are highly susceptible, whereas others are almost completely resistant (for example, BXD87, BXD92 and BXD69). The difference between the cRSI values of parental strains, shown on the two extreme sides of the bar chart (Figure 3 ), was more modest than the variation displayed by the different BXD strains. This finding underscores the complexity of the trait we are measuring (susceptibility/resistance) and highlights the fact that the survival phenotype is modulated by multiple loci.
Following the same method of building a GLM for covariate analysis, we corrected the BI and the log CFU/ spleen by calculating the coefficients that express the contribution of 'mouse strain' as a predictor for BI and for spleen dissemination ( Figure 4) . As shown before with the inverse correlation between survival score and BI (Figure 1c) , most strains that were judged susceptible based on their cRSI (for example, BXD60, BXD66 and BXD75) had higher corrected bacteremia indices (cBIs) and vice versa (for example, BXD69 and BXD73). However, there were exceptions, for example, BXD44 had a negative cRSI and a negative cBI as well, and BXD92 was one of the most resistant strains but showed intermediate -rather than low -bacteremia (Figure 4a) . Additionally, when examining the bacterial dissemination in spleens of different strains (Figure 4b ), most susceptible strains had high dissemination and vice versa, again with exceptions, for example, BXD69. Conversely, the parental strains were this time clearly on two sides of the spectrum, with DBA/2J having the highest spleen dissemination and C57BL/6J having one of the lowest values. Collectively, the data suggest the existence of different mechanisms leading to mortality.
Controlled time-course experiments show the kinetics of bacterial spread and confirm results of population-based experiments
Having generated data with a large number of mice and with strong statistics, we moved to confirm the population-based study through time-course experiments that would clarify the kinetics of bacterial dissemination or clearance in the early hours of infection. In one representative experiment, we selected animals from six strains predicted to have the following descending order of susceptibility BXD61, BXD60, BXD51, BXD73, BXD89, BXD69 (Figure 3a) , and we infected them with the same dose of bacteria and then killed three mice per strain at 18, 36 and 60 h. Overall, the results were as expected: all mice developed bacteremia, and their organs (spleen, lung and liver) were positive for bacterial dissemination, but the kinetics of bacterial dissemination/clearance was quite different. Strains BXD60 and BXD61, predicted as the most susceptible in this experiment, behaved as expected with highest bacterial loads in their spleens and highest rate of bacterial invasiveness, estimated from the slopes of bacterial dissemination in their organs over time ( Figure 5 and Table 3 ). BXD69 was the most resistant strain to bacterial dissemination, with the lowest bacterial loads in organs and a tendency to clear bacteria rapidly (note the negative slopes in Figure 5b -c); this behavior matches its rank as having one of the lowest cRSI ( Figure 3 ) and cBI ( Figure 4a) . A similar pattern was displayed by BXD51, an intermediate strain that tends to have lower bacterial counts in blood and spleen ( Figure 4 ). More interesting, however, was the behavior of BXD73 and BXD89 strains, both of which are resistant strains that showed delayed bacterial clearance in the first 60 h. While BXD73 had bacterial dissemination in organs an order of magnitude lower than BXD60 and BXD61, BXD89's counts seemed to follow the pattern of a susceptible rather than a resistant strain. This under- BXD60  BXD66  BXD75  BXD97  BXD43  BXD61  BXD74  BXD70  BXD85  BXD64  BXD44  BXD69  BXD45  BXD62  BXD51  BXD73  BXD89  BXD92  BXD87  C57BL scores the dissociation between the speed of bacterial dissemination and animal mortality as separate traits. A possible explanation is that BXD89 has an attenuated immune system that may delay bacterial clearance but that does not harm the host.
Preliminary QTL mapping
To provide accurate QTL mapping, we conducted a more extensive study with more strains and more mice per strain. However, with the current number of strains and mice, we used the WebQTL tools on the GeneNetwork web site (http://www.genenetwork.org) and were able to exclude certain sites that could have possibly contributed to the modulation of GAS sepsis severity. For example, our human genetic association studies in patients with severe GAS sepsis revealed a strong association with HLA class II haplotypes. 10 It was therefore interesting to determine whether any QTLs map to the H2 locus. Although the parental strains differed in their H2 types (the C57/BL6 mice are H2-b while the DBA/2J mice are H2-d), we could not find any hint for significant QTLs in the H2 region on chromosome 17. Instead, our preliminary mapping results suggested two significant QTLs on chromosome 2 that we are currently verifying and fine-tuning using additional mice and strains. The insignificant contribution of the mice H2 locus was not entirely surprising because the HLA class II association in humans is related to the role of these molecules in presenting GAS superantigens to T cells. While superantigens play a crucial role in the human disease and in HLA-transgenic mice, 18 they have little contribution in the BXD mouse model because GAS superantigens are poorly presented by mouse H2.
Discussion
Strength of the BXD RI population model Clinical and epidemiological observations provide evidence of strong differences in human susceptibility to GAS infections and the severity and outcomes of diseases caused by the same strain of bacteria.
3,34-37 For example, we have previously demonstrated a dominant effect of HLA class II allelic polymorphisms in severe GAS sepsis. 9, 10 We also provided biological confirmation of these HLA associations in vitro 10, 38, 39 and in vivo.
18
Despite this strong effect of HLA class II polymorphic alleles, we realized that sepsis is a complex disease affected by multiple interactive pathways. To identify additional pathways and polymorphisms contributing to the stark difference in the severity of GAS sepsis, we explored several animal models that may be suitable for this genetic study. While nonhuman primates represent an alternative to study human GAS infections, 40, 41 their use in immunogenetic population studies is expensive and impractical due to their slow breeding pattern and small progeny, high cost and ethical issues. Meanwhile, regular laboratory mice, which share B85% gene content with humans, 42 are not sensitive to invasive GAS infections 43, 44 just as certain human populations are not good models for certain human diseases because of their genetic resistance. This natural resistance of mice to severe GAS sepsis can be overcome by the use of high infectious doses, less resistant strains or transgenic mice carrying human HLA class II 18 or human plasminogen. 45, 46 Despite this, successful attempts were made with standard inbred mouse lines, for example, BALB/c, C3H/HeN and CBA/J, C57BL/10 17 and DBA/2 and C57BL/6 (Kansal and Kotb, personal communication); whereas these studies were quite informative, conventional mouse models are limited in their genetic pool, and thus one may miss important genotype-trait relations. Our choice was thus to use one of the genetically diversified mouse reference populations generated by the international Complex Trait Consortium (CTC). The CTC strategy, known as the collaborative cross, is to construct a very large set of RI strains from a genetically diverse set generated by intercrossing conventional inbred mice. 22, 47, 48 RI strains are an ideal resource for systems biology research as they provide a reproducible, highly varied and diversified yet controlled set of genetic backgrounds for functional genomics, QTL mapping and identification of interactive gene networks modulating disease phenotype. 49 Being inbred, RI strains are perpetually renewable and have many advantages over F2 or backcross populations. Experiments performed with RI mice can be repeated in different laboratories and at different times with expected reproducibility. This adds high statistical power. Because the ancestral parents are fully sequenced, the genotyped RI strains afford a powerful tool for identifying genes within QTLs and are particularly useful for mapping multiple and epistatic genetic effects underlying complex phenotypes, including those seen in infectious diseases. 22, 47, [50] [51] [52] Among the different RI sets of mice, we found the BXD panel more suitable for us than other series (for example, the AXB set) as the BXD series is much larger, almost three-times more than used in any other series of experiments and because both parental strains (C57BL/ 6J and DBA/2J) have been fully sequenced, 30 and have been shown to differ in their response to many pathogens, 28, [53] [54] [55] [56] [57] including GAS (Kansal and Kotb, personal communication).
Complexity of the phenotype Susceptibility to a particular bacterial infection and disease severity are complex phenotypes likely to be contributed by more than one genetic factor, and by networks and pathways modulated by gene products. Our attempt to attribute one or two sets of genetic loci that predispose mice to or protect them from certain infections could be misleading if we fail to take the complexity of the phenotype into consideration. In this study, we explored the response of a panel of 20 BXD RI mice (plus the two parental strains) to infection with the same dose of GAS and monitored them over a week post-infection. To quantify the animals' susceptibility to GAS and the severity of sepsis, we measured three variables: animal survival, bacteremia and dissemination in systemic organs (spleen, liver and lung). Our results provide solid evidence of the complexity of our phenotype. One manifestation of this complexity is that BXD strains exhibited a much wider range of variability in survival (Figure 3 ) and bacteremia (Figure 4a ) than the parental strains; yet, the two ancestral strains were on the two extreme sides of the panel of bacterial dissemination in spleen (Figure 4b ). This behavior is likely a result of the random assortment of many polymorphic loci that accentuate resistance or susceptibility to infection depending on the pattern by which they are inherited from the parental strains to the offspring. Another consequence of the trait complexity is that the different strains did not show identical patterns for the different measured variables (Figures 3 and 4) . There was a significant correlation between survival and bacteremia (Figure 1c ), but it only explained 25% of the variance. Differences in the kinetics of bacterial dissemination to organs of BXD strains in the first 60 h of disease ( Figure 5 and Table 3 ) highlights the uniqueness of each strain, and shows the importance of following the course of infection at multiple time points. Our analysis indicates that bacteremia and dissemination to organs were major predictors of disease severity and mortality; however, it is likely that other factors contribute to mortality, including severe toxicity and inflammatory responses in blood and organs.
Power of statistical analysis A major part of our study was dedicated to the optimization and standardization of this novel mouse model. We conducted preliminary experiments to optimize the inoculum size and volume, the number of mice to be used per strain and the best randomization scheme for injecting mice and recording the data. Subsequently we generated a large data set from 445 mice, and we used this data set to estimate the effect of independent confounding factors like sex, age, body weight and inoculum size (Figure 2) as well as the combined effects of these covariates ( Table 2 ). As a result of these analyses, we filtered our data set, bringing the number of analyzed cases to 307, after excluding animals from strains that were tested only once, and those that did not fall in the age range where age and weight were colinear. The analysis of covariates also helped us to estimate the contribution of each factor in predicting susceptibility to the severe form of GAS sepsis therein allowing us to correct the measurable traits (SI, BI and log CFU/ spleen) for significant covariates. Correction for age, for example, was a vital alternative to age-matching all animals, which is not feasible because the breeding scheme of 20 strains cannot be synchronized practically. The ability to use large number of strains and to repeat experiments using the same strains added power to the statistical analysis. Combining the genetic diversity of the RI strains with statistical analysis allowed the dissection of many factors contributing to infection phenotype using relatively small numbers of animals and a large number of strains.
Preliminary QTL mapping results
It is rather risky to attempt to identify QTLs using only 20 BXD strains, and this was not the intention of this study, which focused on developing the model and identifying significant covariates affecting the severity of GAS sepsis. Nonetheless, we were able to exclude plausible regions as major contributors to GAS sepsis severity. For example, we can comfortably exclude any contribution from the H2 region on chromosome 17. Although our previous studies showed strong association with HLA class II genes, 10, 18 it was not surprising that the mouse H2 allelic variation does not contribute to GAS sepsis severity because the mouse H2 molecules are very poor presenters of GAS superantigens that are pivotal in mediating the pathogenesis of the human disease. The BXD model allows us now to map QTLs and identify additional bacterial virulence strategies involved in the pathogenesis of sepsis. The latter are usually masked by the overwhelming effects of superantigens in human studies and HLA-transgenic mouse model. 10, 18 Preliminary mapping studies pointed to two regions on mouse chromosome 2, which harbor many genes of relevance to immune modulation. Ongoing studies using additional strains are expected to confirm and narrow down these QTLs.
Conclusion
The BXD RI strains afforded good model for the analysis of traits that contribute to severe GAS sepsis. The genetic diversity of these strains exaggerates or suppresses traits seen in the parental strains. Having standardized the model and set major criteria for selecting the animals to be used and analyzed, we will continue generating data by using more BXD strains and bioinformatics tools to map QTLs and determine the genetic basis for the large differences in disease susceptibility among these animals. Mapping QTLs is likely to identify gene variants (polymorphisms, single nucleotide polymorphisms or mutations) that underlie the remarkable individual differences that are a hallmark of host-GAS interactions; however, our long-term goal is to generate a disease roadmap by revealing the networks involved in these interstrain differences.
Materials and methods

Mice
The BXD strains are completely inbred strains generated by repeated mating between siblings starting from F2 intercross progeny between C57BL/6J and DBA/ 2J. 20, 22, 58, 59 In this study, we used 717 mice belonging to a set of 33 BXD strains along with the parental strains, C57BL/6J (B6) and DBA/2J (D2). Among these mice, 218 were used in the preliminary experiments for optimization of inoculum size and experimental conditions, 445 were used in the population-based experiments and 54 were used in the controlled time-course experiments. The animals chosen for final statistical analysis of the population-based experiments (n ¼ 307) were those that satisfied all the conditions determined in the study (see the Results section) and that belonged to a BXD strain that was used in at least two experiments.
The animals were mated and housed in a pathogenfree colony on hardwood chip bedding in microisolator cages at the VA Medical Center and the University of Tennessee Health Science Center, Memphis, TN, USA. They were maintained on a 12 h light-dark cycle, in a room kept at 231C with 50-60% relative humidity; they were given tap water and sterile irradiated rodent chow (Harlan Teklad, Madison, WI, USA) ad libitum. All protocols were approved by the Institutional Animal Care and Use Committees of Veterans Affairs Medical Center and The University of Tennessee.
Bacteria and culture media
We used the clinical isolate, GAS-5448, 60 representative of the clonal M1T1 strain that has globally disseminated since the mid-1980s and was associated with severe and nonsevere GAS infections. 7, 61 The bacteria were incubated in THY, that is, Todd Hewitt Broth (DIFCO, Detroit, MI, USA) supplied with 1.5% of yeast extract (DIFCO), for 17 h, washed twice with sterile phosphatebuffered saline solution, PBS (Gibco, Carlsband, CA, USA), then diluted to the final inoculum size with sterile PBS. The original isolate had been aliquoted in THY stocks containing 15% glycerol (Sigma, St Louis, MO, USA) at À801C. Before each use, the bacteria were spread on blood agar plates (Becton Dickenson, Franklin Lakes, NJ, USA) for colony isolation and sterility checking.
Experimental design and infection scheme Before the start of each experiment, we randomized animals to avoid bias in the order of injection, weighing or sampling. We kept males and females in different cages. Animals were infected via the tail-vein injection with a 271 Â 10 7 CFU/mouse (unless otherwise stated). Twenty-four hours post-infection, blood was sampled for bacteremia: 20 ml was drawn from the tail vein and diluted ten-fold in sterile saline (SS). During the observation period (7 days), animals were weighed twice a day (0800, 0400 hours) and checked for survival three times a day (0800, 0400 hours and at midnight). We dissected spleens, livers and lungs from mice that were killed at specified time points, as well as animals that expired before killing, and we homogenized these tissues using a rotor stator homogenizer (Omni International, Marietta, GA, USA) in SS and a sample was used to estimate bacterial loads.
Design of controlled time-course experiments
Time-course experiments were designed to investigate the kinetics of bacterial dissemination in the early stages of the infection. These experiments were performed following the same procedure as the population-based experiments (see above), except that equal numbers of animals belonging to each strain (typically three animals per strain per time point) were sampled for blood, spleen, liver and lung at 18, 36 and 60 h post-infection. Regardless of the specified sampling time, all animals were bled through the tail vein (20-30 ml) for determination of bacteremia at 18 h. At each time point, the animals were dissected, and their organs (spleens, livers and lungs) were homogenized in 10 ml SS each.
Bacterial loads in blood and organs
To determine bacterial loads in blood and organ homogenates, we diluted 10 ml of either sample (tail-vein blood or homogenate) serially (up to 10
À7
) and plated 10 ml of each dilution (as well as the original sample) on the surface of blood agar plates (Becton Dickenson). After 24 h incubation, all plates were counted, and the number of CFUs per milliliter or per organ was calculated (CFU/organ ¼ CFU/ml homogenate Â 10).
Data handling and statistical analysis
Results were recorded three times daily (or whenever an animal died). Data were reviewed for accuracy and consistency at the end of every experiment by a different set of investigators. We dedicated a considerable amount of time to data recording, error checking and filtration after each experiment. Mice lost due to factors unrelated to infection were flagged in the database and excluded from the final analysis. We performed all primary calculations and sorting operations using simple features and functions of Microsoft Excel. Excel files were later exported to Data Desk (version 6.2) software (Data Description Inc., Ithaca, NY, USA; www.datadesk.com), which we used for all statistical analyses and tests, including clustering, correlation analysis, linear regression, multiple regression and general linear model (GLM) analysis by OLS ANOVA.
Preliminary QTL mapping
For QTL mapping, we used the Web-based complex trait analysis platform, WebQTL 62 available on the GeneNetwork Web site (http://www.genenetwork.org). WebQTL evaluates potential QTL at regular intervals and estimates the significance at each location with a graphical representation of the likelihood ratio statistics (LRS).
